Onvansertib
Onvansertib Uses, Dosage, Side Effects, Food Interaction and all others data.
Onvansertib is under investigation in clinical trial NCT03303339 (Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML).).
| Trade Name | Onvansertib |
| Generic | Onvansertib |
| Onvansertib Other Names | Onvansertib |
| Type | |
| Formula | C24H27F3N8O3 |
| Weight | Average: 532.5182 Monoisotopic: 532.215821385 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Onvansertib
